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1. Introduction 
Ulcerative colitis is occasionally exacerbated by fulminant manifestation of colitis. Severe 
ulcerative colitis is usually defined based on Trulove and Witts’ criteria (Table 1) (Truelove 
& Witts, 1955). The incidence of severe colitis in ulcerative colitis is 5 to 15 percent (Chen et 
al., 1998). If the patient is not improving despite intensive medical therapy, emergency 
colectomy is mandatory. In such a case, the patient is often malnourished and anemic, and 
has received high dose of steroids; therefore, the usual option in patients with severe 
ulcerative colitis is subtotal colectomy and ileostomy with preservation of the rectum 
(Gurland & Wexner, 2002). Restorative proctectomy can be done at a later time after the 
patient has recovered fully and steroids have been withdrawn (Fig. 1). 
 
(1) >6 stools/day 
(2) Bloody diarrhea 
(3) Fever ≥37.5°C 
(4) Heart rate ≥90/ min 
(5) Hemoglobin ≤10g/dl 
(6) Erythrocyte sedimentation rate ≥30mm/hr 
Table 1. Definition of severe ulcerative colitis based on Trulove and Witts’ criteria (Truelove 
& Witts, 1955). When criteria (1) and (2) are applied, either criterion (3) or (4) is applied, and 
four of the six criteria are applied, the ulcerative colitis is diagnosed as severe 
The earliest reports of the laparoscopic approach to ulcerative colitis in the elective setting 
are from the early 1990s (Peters, 1992; Wexner et al., 1992). These first results did not seem 
very promising, the laparoscopic technique appeared too difficult to apply, too time-
consuming, and comorbidity was high. The authors discouraged the use of laparoscopic 
approach for patients requiring total colectomy. However, with advances in technology and 
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experience of laparoscopic surgery, more favourable results have been stated (Marcello et 
al., 2000; Brown et al., 2001; Hamel et al., 2001; Hashimoto et al., 2001; Seshadri et al., 2001; 
Ky et al., 2002; Gill et al., 2004; Kienle et al., 2005; Larson et al., 2005). These reports have 
shown the advantages of laparoscopic total colectomy such as reduced postoperative pain, 
earlier return of intestinal function, decreased length of hospital stay, and improved 
cosmesis (Table 2). On the basis of these results, recent studies have evaluated the feasibility 
and safety of minimally invasive surgery for selected patients with severe ulcerative colitis. 
Minimally invasive surgery techniques include laparoscopic-assisted colectomy and hand-
assisted laparoscopic surgery. In this article, an overview of current status of minimally 
invasive surgery to severe ulcerative colitis is provided. 
 
 
 
 
Fig. 1. Three-stage restorative proctocolectomy for severe ulcerative colitis 
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Author 
(year) 
Number of patients 
Operative time 
 (min) 
Conversion 
(%) 
 Lap Open Lap Open P-value Lap 
Marcello 
(2000) 
20 
(UC;13 
FAP;7) 
20 
(UC;13 
FAP;7) 
330 225 <0.001 0 
Hashimoto 
(2001) 
11 
(UC;6 
FAP;5) 
13 
(UC;6 
FAP;7) 
483 402 <0.05 0 
Gill 
(2004) 
14 
(UC;13 
FAP;1) 
- 260 - - 7 
Kienle 
(2005) 
50 
(UC;23 
FAP;27) 
- 320 - - 8 
Larson 
(2005) 
33 
(UC;31 
FAP;2) 
33 
(UC;31 
FAP;2) 
- - - - 
UC: ulcerative colitis, FAP: familial ademnomatous polyposis 
Table 2. Perioperative data from clinical trials treating laparoscopic-assisted restorative 
proctocolectomy and ileo-anal anastomosis in elective setting 
 
Author Hospital stay (days) Morbidity (%) 
 Lap Open P-value Lap Open P-value 
Marcello 7 8 0.02 20 25 NS 
Hashimoto 24.1 31.3 <0.05 55 38 0.453 
Gill 7 - - 29 - - 
Kienle 12 - - 30 - - 
Larson - - - 6 12 0.39 
Table 2 (continued). Perioperative data from clinical trials treating laparoscopic-assisted 
restorative proctocolectomy and ileo-anal anastomosis in elective setting 
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Author Conclusion 
Marcello 
Technically feasible and safe. Shorter hospital stay. Quicker return of bowel 
function. 
Complication rates were similar to open surgery. 
Hashimoto 
Better cosmetic results. Reduce the degree of postoperative pain. Shorter 
hospital stay. 
Gill Technically feasible. Operative time was acceptable. 
Kienle 
Technically feasible. LAP may reduce the need for perioperative blood 
transfusion. 
Larson 
The function and quality of life outcomes seemed to be equivalent to open 
surgery. 
Table 2 (continued). Perioperative data from clinical trials treating laparoscopic-assisted 
restorative proctocolectomy and ileo-anal anastomosis in elective setting 
2. Indication for minimally invasive surgery in severe ulcerative colitis 
Patients are usually hospitalized and received intensive medical therapy when their severe 
colitis is diagnosed. The mainstay of treatment for severe ulcerative colitis is Truelove’s 
intensive intravenous steroid regimen (Truelove & Jewell 1974). Immunosuppressive 
therapy, cytapheresis therapy, and/or steroid pulse therapy are considered as alternative 
treatment options (Lichtiger et al., 1994; Sawada et al., 1995; Sood et al., 2002). Total 
parenteral nutrition, albumin and blood transfusion, and/or antibiotic therapy are 
considered as supportive therapies. Surgery is indicated when the patients are unresponsive 
to medical therapy, or when massive hemorrhage, toxic megacolon, or perforation occurs. 
Patients with severe ulcerative colitis are often malnourished and anemic, and has received 
high dose of steroids, which increase the likelihood of postoperative complications. 
Minimally invasive surgery for severe ulcerative colitis is technically difficult because of 
active inflammation and induration of the mesentery, fragile intestinal tissue, abscesses 
between intestinal loops, and dense adhesions. To date, there is no randomized controlled 
trial assessing minimally invasive surgery for severe ulcerative colitis. In most retrospective 
studies, the patients with complications such as toxic megacolon, intestinal perforation, 
peritonitis, or shock stage were excluded from the indication for minimally invasive surgery 
(Table 3). 
 
(1) Toxic megacolon 
(2) Intestinal perforation 
(3) Peritonitis 
(4) Shock status 
Table 3. Exclusion criteria for minimally invasive surgery in severe ulcerative colitis 
3. Laparoscopic-assisted subtotal colectomy for severe ulcerative colitis 
Several recent studies have reported the outcome of laparoscopic-assisted subtotal 
colectomy in selected patients with severe ulcerative colitis (Table 4). In most of these 
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studies, patients with complications such as toxic megacolon, intestinal perforation, peritonitis, 
or shock status were excluded from the indication for minimally invasive surgery. 
 
Author 
(year) 
Number of patients 
Operative time 
 (min) 
Conversion 
(%) 
 Lap Open Lap Open P-value Lap 
Telem 
( 2010) 
29 61 216 170 <0.01 7 
Maggiori 
(2010) 
35 
(UC;27 CD;8) 
- 252 - - 6 
Fowkes 
(2008) 
32 - 135 - - 3 
Maeceau 
(2007) 
40 
(UC;26CD;13 
IC;1) 
48 
(UC;14 
CD;29 
IC;5) 
253 231 NS 5 
Bell 
(2002) 
18 6 
220 
~ 
360 
- - 0 
Dunker 
(2000) 
10 
(UC;8 
CD;2) 
22 
(UC;27 
CD;5) 
271 150 <0.001 0 
UC: ulcerative colitis, FAP: familial ademnomatous polyposis 
Table 4. Perioperative data from clinical trials treating laparoscopic-assisted subtotal 
colectomy for severe ulcerative colitis 
Telem et al (Telem et al., 2010) from the Mount Sinai Medical Center, New York City 
evaluated laparoscopic-assisted subtotal colectomy (n=29) versus open subtotal colectomy 
(n=61) in patients with ulcerative colitis requiring urgent or emergent operative intervention. 
Two (7%) patients in the laparoscopic group required conversion to open surgery. The mean 
operative time was significantly longer in the laparoscopic group (216.4 vs. 169.9 min, 
P<0.01). Intraoperative blood loss was significantly lower in the laparoscopic group (130.4 
vs. 201.4 ml, p<0.05). The mean hospital stay was shorter in laparoscopic group (4.53 vs. 6 
days, p<0.001). The rate of wound complication was significantly lower in laparoscopic 
group (0 vs. 21 percent, p<0.01). 
Maggiori et al (Maggiori et al., 2010) from Beaujon Hospital, France evaluated the outcome 
of laparoscopic-assisted subtotal colectomy with double end ileo-sigmoidostomy in patients 
with acute or severe colitis. The medical records of 35 patients (Ulcerative colitis, n=27; 
Crohn’s disease, n=8) were reviewed. Two (6%) patients required conversion to open 
surgery because of intra-abdominal adhesions (n=1), and complicated case with perforated 
acute colitis (n=1). The mean operative time was 252 minutes. The mean hospital stay was 8 
days. Five (15%) patients experienced postoperative complications and no reoperation was 
needed. With a mean delay of 80 ± 20 days (range: 43 to 129 days), intestinal continuity was 
restored in 100 percent of the cases. 
Fowkes et al (Fowkes et al., 2008) from Frenchay Hospital, United Kingdom analyzed 
surgical outcomes of fulminate and medically resistant ulcerative colitis carried out 
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laparoscopically. The medical records of 32 patients were reviewed. One (3%) patient required 
conversion to open surgery because of a small, localized perforation (unsuspected 
preoperatively). The median operative time was 135 minutes. The median hospital stay was 8 
days. Twelve (38%) patients experienced postoperative complications. They concluded that 
laparoscopic-assisted subtotal colectomy in fulminant and medically resistant ulcerative colitis 
was feasible, safe and largely predictable operations that allow for early hospital discharge. 
 
Author 
(year) 
Hospital stay (days) Morbidity (%) 
 Lap Open P-value Lap Open P-value 
Telem 
(2010) 
4.5 6 <0.001 
28 
 
Wound 
complication 
0 
34 
 
Wound 
complication 
21 
NS 
 
 
<0.01 
Maggiori 
(2010) 
8 - - 15 - - 
Fowkes 
(2008) 
8 - - 38 - - 
Maeceau 
(2007) 
9 12 
NS 
(<0.10) 
35 56 
NS 
(<0.10) 
Bell 
(2002) 
5.1 8.8 <0.05 33 - - 
Dunker 
(2000) 
14.6 18.0 0.05 
Minor 
complication 
10 
 
Major 
complication 
30 
Minor 
complication2
5 
 
Major 
complication2
8 
0.41 
 
 
 
1.00 
Table 4 (continued). Perioperative data from clinical trials treating laparoscopic-assisted 
subtotal colectomy for severe ulcerative colitis 
Marceau et al (Marceau et al., 2007) from Beaujon Hospital, France conducted a case-
matched study to assess the feasibility and safety of laparoscopic-assisted subtotal 
colectomy (n=40) (Ulcerative colitis, n=14; Crohn’s disease, n=29; Indeterminate colitis, n=5) 
compared with open subtotal colectomy (n=48) (Ulcerative colitis, n=26; Crohn’s disease, 
n=13; Indeterminate colitis, n=1) in patients with severe colitis. Two (5%) patients required 
conversion to open surgery because of intensive adhesions (n=1) and colonic fistula (n=1). 
Between the laparoscopic group and open group, the mean operative time (253 vs. 231 min), 
overall morbidity (35 vs. 56%), and hospital stay (9 vs. 12 days) were similar. After a follow-
up of 3 ± 4 months after the first operation, 35 patients (88%) have had restorative intestinal 
continuity through laparoscopic approach or elective incision at the site of previous stoma. 
They concluded that laparoscopic-assisted subtotal colectomy was as safe and effective as 
open subtotal colectomy for patients with severe colitis complicating inflammatory bowel 
disease.  
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Bell et al (Bell & Seymour 2002) from Yale University School of Medicine, New Haven 
reported surgical outcomes of fulminant ulcerative colitis carried out laparoscopically. The 
medical records of 18 patients with poorly controlled fulminant ulcerative colitis on 
aggressive immunosuppressive therapy who underwent laparoscopic subtotal colectomy 
were reviewed. None of the laparoscopic procedures required conversion to an open 
operation, and there were no intraoperative complications. The total operative time ranged 
from 220 to 360 min. Procedure length diminished significantly over the course of the series; 
the operative time during the last six procedures was 244 vs. 275 minutes during the prior 
12 patients. Postoperative hospital stay was 5.0 days vs. 8.8 days (p<0.05) for a group of 6 
patients who had undergone open subtotal colectomy for the same indications. 
Postoperative complications occurred in 6 (33%) patients. 
 
Author 
(year) 
Conclusions 
Telem 
(2010) 
Technically feasible and safe. Improved cosmesis. Reduced intraoperative 
blood loss. Negligible wound complications. Shorter hospital stay. 
Maggiori 
(2010) 
Low morbidity. Facilitated second step of intestinal continuity restoration for 
both ileorectal and ileo-anal anastomosis. 
Fowkes 
(2008) 
Technically feasible and safe. Shorter hospital stay.  
Facilitated subsequent proctectomy and pouch construction. 
Marceau 
(2007) 
Operative time, overall morbidity, and hospital stay were similar to open 
surgery.  
84% of the patients underwent restorative intestinal continuity 
Bell 
(2002) 
Technically feasible. Shorter hospital stay.  
Facilitated subsequent proctectomy and pouch construction. 
Dunker 
(2000) 
Technically feasible and safe. Shorter hospital stay. Longer operative time. 
Table 4 (continued). Perioperative data from clinical trials treating laparoscopic-assisted 
subtotal colectomy for severe ulcerative colitis 
Dunker et al (Dunker et al., 2000) from Academic Medical Center, Netherlands evaluated 
the feasibility and safety of emergency laparoscopic-assisted subtotal colectomy in patients 
with severe acute colitis. The medical records of 42 consecutive patients (Laparoscopic 
group; n=10, Open group; n=32) were reviewed. No patients in laparoscopic group required 
conversion to open surgery. The mean operative time was longer in laparoscopic group than 
in the open group (271 vs. 150 minutes). Postoperative hospital stay was significantly 
shorter in the laparoscopic group than in the open group (14.6 vs. 18.0 days. Complications 
were similar for the two groups. They concluded that laparoscopic-assisted subtotal 
colectomy in patients with severe acute colitis was feasible and safe as open colectomy. 
4. Hand-assisted laparoscopic subtotal colectomy for severe ulcerative 
colitis 
Standard laparoscopic assisted subtotal colectomy for severe ulcerative colitis is still 
technically difficult because of bowel friability and hypervascularity, creating a high 
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likelihood of perforation and bleeding. Hand-assisted laparoscopic surgery is a technique in 
which laparoscopic procedures are performed with the aid of a hand inserted into the 
abdomen through a small incision. (Ballantyne & Leahy, 2004; Nakajima et al., 2004; 
Rivadeneira et al., 2004; Boushey et al., 2007). Surgeons are abled to obtain tactile sensation, 
manual retraction, and digital vascular control, which could allow complex laparoscopic 
operations to be performed more effectively and satisfactorily. A few recent studies have 
reported hand-assisted laparoscopic subtotal colectomy for selected patients with severe 
ulcerative colitis (Watanabe et al., 2009; Holubar et al., 2009; Chung et al., 2009). 
4.1 Surgical technique for hand-assisted laparoscopic subtotal colectomy 
The patient was placed in the supine position with legs moderately opened. A 70-mm lower 
paramedian incision was made and the abdomen was entered (Fig. 2). The ascending and 
descending colon was manually mobilized through the incision. After the mobilization, the 
hand port was placed in the lower paramedian incision. A 12-mm trocar was inserted above 
the umbilicus for laparoscope and pneumoperitoneum. A 5-mm or 12-mm trocar was 
inserted in the lower left abdomen for dissection. If necessary, the third 5-mm or 12-mm 
trocar was inserted in the upper left abdomen. The greater omentum was dissected and 
splenocolic and hepatocolic ligaments were taken down to mobilize the transverse colon by 
use of a Harmonic ScalpelTM (UltraCision, Smithfield, RI) or LigaSureTM (Tyco Healthcare 
Japan, Tokyo, Japan) (Fig.3, 4). The mesocolon was also dissected. The ileocolic artery was 
preserved in all patients to provide optimal blood supply to the distal ileum. After this, the 
laparoscopic procedure was ended. Transsection of the terminal ileum and proximal rectum 
were performed with a linear stapler, and the colon was taken out through the lower 
paramedian incision. A mucous fistula of the rectum was constructed in the left lower 
abdomen, and a standard Brooke ileostomy was fashioned in the right lower abdomen (Fig. 5). 
4.2 Hand-assisted laparoscopic surgery for severe ulcerative colitis 
A few recent studies have evaluated the outcome of hand-assisted laparoscopic subtotal 
colectomy in patients with severe ulcerative colitis. 
The authors (Watanabe et al., 2009) from Tohoku University Graduate School of Medicine, 
Japan recently reviewed the medical records of 60 patients who underwent emergency 
subtotal colectomy with hand-assisted laparoscopic technique (n=30) or conventional open 
technique (n=30) for severe ulcerative colitis. One (3%) patient in the laparoscopic group 
required conversion to open surgery because of excessive inflammatory adhesion. The 
median operative time was significantly longer in the hand-assisted laparoscopic surgery 
group than in the open surgery group (242 vs. 191 minutes; P<0.001). The median time to 
first solid diet in the hand-assisted laparoscopic surgery group was significantly shorter 
than that in the open surgery group (4.8 vs. 5.9 days; P=0.007). The postoperative hospital 
stay in the hand-assisted laparoscopic surgery group was significantly shorter than in the 
open surgery group (23.0 vs. 33.0 days; P=0.001). The number of postoperative 
complications during the hospital stay in the hand-assisted laparoscopic surgery group was 
significantly less than in open surgery group (37 vs. 63%; P = 0.041). Four (13%) patients in 
the open surgery group required relaparotomy because of peritoneal abscess (two patients) 
or strangulation ileus (two patients), but no patients needed relaparotomy in the hand-
assisted laparoscopic surgery group (P=0.040). In the open surgery group, 4 of 30 patients 
(13%) had surgical site infection and 2 patients among them developed wound dehiscence 
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and needed resuture of the wound. In the hand-assisted surgery group, 4 of 30 patients 
(13%) had surgical site infection, but no patient developed wound dehiscence. The authors 
concluded that hand-assisted laparoscopic surgery can be an alternative to conventional 
open surgery for severe ulcerative colitis. 
conversion to open surgery was 2 (5.5%) in laparoscopic-assisted surgery group, and 1 
(7.1%) in hand-assisted laparoscopic surgery group, respectively. The median operative time 
was 251 minutes. The median hospital stay was 4 days. Seventeen (34%) patients 
experienced postoperative complications and 2 (4%) patients required reoperation. The most 
frequent complications after each procedure were ileus (8%) and surgical site infections (4%). 
 
 
Fig. 2. Port and incision placement for hand-assisted laparoscopic subtotal colectomy 
(above). Operative scars after hand-assisted laparoscopic subtotal colectomy (below) 
12 mm 
5-12 mm 
5-12 mm 
(Optional)
70 mm
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Fig. 3. Mobilization of the transverse colon using hand-assisted laparoscopic technique. 
Splenocolic ligament was taken down from the descending colon to the transverse colon 
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Fig. 4. Mobilization of the transverse colon using hand-assisted laparoscopic technique. 
Splenocolic ligament was taken down from the transverse colon to the descending colon 
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Fig. 5. Operative scars after three-stage hand-assisted laparoscopic proctocolectomy 
Holubar et al (Holubar et al., 2009) from Mayo Clinic, Rochester evaluated the safety and 
feasibility of minimally invasive subtotal colectomy for fulminant ulcerative colitis. The 
medical records of 50 patients (Laparoscopic-assisted surgery; n=36, Hand-assisted 
laparoscopic surgery; n=14) were reviewed. The number of patients who required Chung et 
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al (Chung et al., 2009) from Washington University School of Medicine, St. Louis compared 
short-term outcomes of minimally invasive vs. open subtotal colectomy for severe ulcerative 
colitis. The medical records of 81 patients (Laparoscopic-assisted surgery; n=17, Hand-
assisted laparoscopic surgery; n=20, Open surgery; n=44) were reviewed. Two (11.8%) 
patients in minimally invasive surgery group required conversion to open surgery because 
of bleeding from the middle colic vessels, and colonic injury with feculent spillage. 
Intraoperative intravenous fluid volume, operative time, and estimated blood loss were 
increased in the minimally invasive surgery group. Short-term recovery (return of bowel 
function, length of stay, inpatient narcotic use, and complication rate) was significantly 
lessened in the minimally invasive surgery group. The minimally invasive surgery group 
completed all three stages a mean of 66 days sooner than the open surgery group (188.9 vs. 
255.36 days, P = 0.0038). 
 
Author 
(year) 
Number of patients 
Operative time 
 (min) 
Conversion (%) 
 MIS Open MIS Open P-value MIS 
Watanabe 
(2009) 
HALS;30 30 242 191 <0.001 3 
Holubar 
(2009) 
HALS;14 
LAP;36 
- 251 - - 
HALS;7.1 
LAP;5.5 
Chung 
(2009) 
HALS;20 
LAP;17 
44 223 140 <0.001 
Overall; 
11.8 
MIS: minimally invasive surgery 
Table 5. Perioperative data from clinical trials treating laparoscopic-assisted subtotal 
colectomy for severe ulcerative colitis 
 
Author 
(year) 
Hospital stay (days) Morbidity (%) 
 MIS Open P-value MIS Open P-value 
Watanabe 
(2009) 
23 33 0.001 37 63 0.041 
Holubar 
(2009) 
4 - - 34 - - 
Chung 
(2009) 
4.9 8.5 0.039 24 48 0.039 
  MIS: minimally invasive surgery 
Table 5 (Continued). Perioperative data from clinical trials treating laparoscopic-assisted 
subtotal colectomy for severe ulcerative colitis 
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Author 
(year) 
Conclusions 
Watanabe 
(2009) 
Technically feasible and safe. Longer operative time. Shorter hospital stay. 
Reduced postoperative complication rate. 
Holubar 
(2009) 
Technically feasible and safe. Shorter hospital stay. 
Chung 
(2009) 
Safe. Associated with short-term benefits that may lead to faster recovery 
and progression to completion of restorative proctocolectomy. 
Table 5 (continued). Perioperative data from clinical trials treating laparoscopic-assisted 
subtotal colectomy for severe ulcerative colitis 
5. Conclusion 
The earliest reports of the laparoscopic approach to ulcerative colitis in the elective setting 
provided little evidence of significant benefit over the standard open operative approach 
(Peters 1992; Wexner et al. 1992). However, with advances in technology and experience of 
laparoscopic surgery, more favourable results have been stated. Several studies have 
reported the feasibility and safety of laparoscopic assisted total colectomy for ulcerative 
colitis in the elective setting, and shown the advantages of laparoscopic assisted total 
colectomy such as reduced postoperative pain, earlier return of intestinal function, 
decreased length of hospital stay, and improved cosmesis (Marcello et al., 2000; Hashimoto 
et al., 2001; Seshadri et al., 2001; Gill et al., 2004; Kienle et al., 2005; Larson et al., 2005). On 
the basis of these results, several studies have evaluated the feasibility and safety of 
minimally invasive surgery for selected patients with severe ulcerative colitis (Dunker et al., 
2000; Bell & Seymour, 2002; Marceau et al., 2007; Fowkes et al., 2008; Watanabe et al., 2009; 
Holubar et al., 2009; Chung et al., 2009; Maggiori et al., 2010; Telem et al., 2010). These 
retrospective trials indicated that minimally invasive subtotal colectomy for selected 
patients with severe ulcerative colitis associated with a marked reduction in wound 
complication rate, time to return of bowel function, and mean hospital stay, although most 
of these studies have reported that the mean operating time was longer than open surgery. 
The role of minimally invasive surgery for patients with severe ulcerative colitis is still not 
well defined because there is no randomized clinical trial; however, the reproducibility of 
the results among many institutions provides adequate evidence to demonstrate clear 
advantages of minimally invasive surgery for severe ulcerative colitis over a conventional 
open surgery. Laparoscopic assisted surgery for severe ulcerative colitis is still technically 
difficult because of bowel friability and hypervascularity, creating a high likelihood of 
perforation and bleeding. A few recent studies assessed hand-assisted laparoscopic surgery 
for selected patients with severe ulcerative colitis (Watanabe et al., 2009; Holubar et al., 2009; 
Chung et al., 2009). The use of this technique may be adequate for severe ulcerative colitis 
because hand-assisted surgery enables surgeons to obtain tactile sensation, manual 
retraction, and digital vascular control, which could allow complex laparoscopic operations 
to be performed more effectively and satisfactorily. Further evidence based study is needed 
to clarify the role of laparoscopic assisted or hand-assisted laparoscopic surgery for severe 
ulcerative colitis. 
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